You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 13, 2024

Vilazodone hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for vilazodone hydrochloride and what is the scope of patent protection?

Vilazodone hydrochloride is the generic ingredient in two branded drugs marketed by Abbvie, Accord Hlthcare, Alembic, Apotex, Invagen Pharms, and Teva Pharms Usa, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for vilazodone hydrochloride. Thirteen suppliers are listed for this compound.

Recent Clinical Trials for vilazodone hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Alliance on Mental Illness Montana
CGStat LLC
University of New Mexico

See all vilazodone hydrochloride clinical trials

Medical Subject Heading (MeSH) Categories for vilazodone hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for vilazodone hydrochloride
Paragraph IV (Patent) Challenges for VILAZODONE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VIIBRYD Tablets vilazodone hydrochloride 10 mg, 20 mg, and 40 mg 022567 5 2015-01-21

US Patents and Regulatory Information for vilazodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208228-002 Jul 7, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-003 Jan 21, 2011 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Accord Hlthcare VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208209-002 Apr 27, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Invagen Pharms VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208200-003 Dec 6, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-001 Jan 21, 2011 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for vilazodone hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbvie VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-001 Jan 21, 2011 ⤷  Sign Up ⤷  Sign Up
Abbvie VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-003 Jan 21, 2011 ⤷  Sign Up ⤷  Sign Up
Abbvie VIIBRYD vilazodone hydrochloride TABLET;ORAL 022567-002 Jan 21, 2011 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.